Shares of DaVita Inc. /zigman2/quotes/204229673/composite DVA +1.00% slipped 1.71% to $91.42 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -0.22% falling 1.13% to 3,855.93 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.01% falling 1.01% to 30,706.23. The stock's fall snapped a three-day winning streak. DaVita Inc. closed $33.39 short of its 52-week high ($124.81), which the company achieved on April 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Fresenius Medical Care AG & Co. KGaA ADR /zigman2/quotes/210057637/composite FMS +1.64% fell 3.70% to $15.89, Laboratory Corp. of America Holdings /zigman2/quotes/203174601/composite LH +0.61% fell 1.49% to $220.21, and Universal Health Services Inc. Cl B /zigman2/quotes/208539347/composite UHS -0.19% fell 2.65% to $96.14. Trading volume (620,805) remained 130,873 below its 50-day average volume of 751,678.